XML 41 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Oct. 02, 2016
Oct. 25, 2016
Jun. 30, 2016
May 31, 2016
Dec. 31, 2015
Jan. 31, 2015
Sep. 30, 2014
Aug. 31, 2012
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2017
Jun. 30, 2016
Operating lease periodic payment     $ 709     $ 730              
Frequency of periodic payment     Monthly     Monthly              
Operating lease rental expense                 $ 2,126 $ 709   $ 4,251 $ 709
Operating lease expiration date           Nov. 30, 2015              
SkyPharm [Member]                          
Operating lease periodic payment             $ 4,802            
Operating lease rental expense                 25,198 19,856   50,397 37,670
Term of operating lease             6 years            
SkyPharm [Member] | Additional space [Member]                          
Operating lease periodic payment     $ 2,021 $ 886                  
SkyPharm [Member] | First Floor [Member]                          
Operating lease periodic payment         $ 886                
Amplerissimo [Member]                          
Operating lease periodic payment               $ 122          
Frequency of periodic payment               Monthly          
Operating lease rental expense                 $ 358 $ 368   $ 715 $ 737
Operating lease expiration date               Jul. 31, 2013          
Operating lease renewal date               Jul. 31, 2015          
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member]                          
Operating lease periodic payment $ 1,500                        
Common stock shares reserved 2,000,000                        
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Phase III testing [Member]                          
Common stock shares reserved 500,000                        
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Phase II testing [Member]                          
Common stock shares reserved 500,000                        
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | conclusion of Phase I testing [Member]                          
Common stock shares reserved 500,000                        
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Preclinical Trials [Member]                          
Common stock shares reserved 500,000                        
Decahedron [member]                          
Operating lease periodic payment   $ 2,415                      
Operating lease rental expense                     $ 12,076    
Term of operating lease   1 year